Abstract Surgical treatment of cervical spondylotic myelopathy (CSM) aims to prevent or delay the progression of the disease. Many patients are diagnosed in advanced stages of the disease, presenting severe functional disability and extensive radiologic changes, which suggests clinical irreversibility. There are doubts about the real benefit of surgery in patients who are seriously ill, bedridden or in a wheelchair. The objective of the study is to evaluate the effects of surgical treatment in the clinical outcomes of patients severely affected by CSM. We analyzed patients with CSM who received an operation at a single institution between 1996 and 2008. Cases with a preoperative Nurick score equal to 5 were studied. We describe postoperative clinical improvement and compare the demographics and clinical data between the patients who improved and those who had no improvement. Radiological findings were also analyzed. We evaluated 55 patients operated on. Nine presented with preoperative Nurick score of 5 (16.3%). The mean age was 69.77 ± 6.6 years (95% CI 64.65-79.90). The mean follow-up was 53.44 ± 35.09 months ). Six patients (66.6%) achieved functional improvement when assessed by the Nurick scale, regaining the ability to walk. All patients improved on the JOAm scale, except one. The mean preoperative Nurick score was 5, while the mean postoperative Nurick score was 4.11 ± 0.92 (95% CI 3.39-4.82) (Wilcoxon p = 0.027). The mean preoperative JOAm score was 6.4, and postoperative was 9.88 ± 2.31 (CI 95% 8.10-11.66) (Wilcoxon p = 0.011). All spinal cords presented high-intensity signal on T2-weighted images. There was no correlation between the number of spinal cord high-intensity signal levels and clinical improvement. Three out of seven patients (whose image was adequate for analysis) had evident spinal cord atrophy, and two of them did not improve clinically. In the whole sample of patients, the mean length of disease for those who improved was 9.25 ± 7.31 months (95% CI 1.56-16.93), and for those who did not improve was 38.00 ± 19.28 months (95% CI 9.91-85.91) (MannWhitney p = 0.02). In conclusion, two-thirds of patients with CSM Nurick scores of 5 who were either bedridden or in wheelchairs at the time of diagnosis improved at least one degree on the Nurick scale after surgical treatment, thus returning to walking. The JOAm scale was more sensitive to clinical changes than the Nurick scale. Patients with longer lengths of disease had worse outcomes.
Introduction
Cervical spondylotic myelopathy (CSM) is the most common disease of the cervical spinal cord in elderly people [1] . CSM is caused by cervical spondylosis, which is secondary to degenerative spine changes related to age. In addition, CSM often occurs in patients with a previously narrow vertebral canal. Although there are several possible courses of development for CSM, including the stabilization of symptoms, this disease often presents a progressive clinical deterioration and may lead to severe disability [2] .
Although surgical treatment of CSM aims to, at least, prevent or delay the progression of the disease, clinical improvement is frequently observed postoperative. Some clinical factors, such as length of disease and neurological status at diagnosis, are considered to be related to the prognosis with regard to neurological recovery; as a result, patients with longer lengths of disease or poor neurological status at diagnosis have poor prognoses.
There are doubts about the real benefit of surgery in patients who are seriously ill, bedridden or in a wheelchair. The literature addressing the surgical treatment of patients in advanced stages of CSM is scarce, consisting of articles with small samples; this is likely due to the fact that there are doubts about the benefits of surgery in these cases.
Objective
To evaluate the effects of surgical treatment on the clinical outcomes of patients severely affected by CSM.
Methods
We analyzed patients with CSM who received an operation at a single institution between 1996 and 2008. The patients were classified according to the Nurick's classification of disability (Table 1) [3] . Cases with a preoperative Nurick score equal to 5 were studied (patients who were bedridden or in wheelchairs at the time of diagnosis). Neurological and functional status were assessed at admission and in July 2008. Those patients with preoperative Nurick scores less than 5 and those with co-morbidities that affect gait were excluded.
We also used the evaluation system proposed by the Japanese Orthopedic Association (JOAm) modified by Benzel et al. [4] , which incorporates analysis of the upper limbs. This scale was also used to permit detection of any changes in the patient's clinical status (Table 2 ).
In addition, we compare the demographics and clinical data between patients who improved and those who had no improvement.
The decision-making process was based on the original algorithm proposed by Naderi et al. [5] . In the presence of an effective kyphosis or ventral spinal cord compression up to three levels, the anterior surgical approach was used. In patients with maintenance of an effective lordosis or dorsal compression the posterior approach was elected. In the cases with straightened spine, the position of spinal cord compression was essential for the decision-making. Patients with spondylolisthesis or straightened spine operated by dorsal approach were fused and instrumented using lateral masses screw systems ( Fig. 1 ).
Statistics
Demographic data are described using the mean, standard deviation and confidence interval (CI) 95%. The distributions of the pre-and postoperative Nurick and JOAm scale scores are described by the mean, standard deviation and CI 95%. Differences in distribution were analyzed by the Wilcoxon test.
Results
We evaluated 55 patients operated during the study period. Nine presented with Nurick scores of 5 (16.3%) and were selected for analysis. The demographic and clinical data of these patients are presented in Table 3 .
The mean age of the patients was 69.77 ± 6.6 years (95% CI 64.65-79.90) and the mean follow-up was 53.44 ± 35.09 months (CI 26.46-80.42).
Results of surgery
Six patients (66.6%) achieved functional improvement when assessed by the Nurick scale, regaining the ability to walk. All patients improved on the JOAm scale, except one patient who had the same score postoperatively ( Table 3) .
The mean preoperative Nurick score was 5 (range 5-5), and the mean postoperative Nurick score was 4.11 ± 0.92 (95% CI 3.39-4.82) (Wilcoxon p = 0.027). The mean preoperative JOAm score was 6.4 ± 2.06 (CI 95% 4.85-8.03), and the mean postoperative JOAm score was 9.88 ± 2.31 (CI 95% 8.10-11.66) (Wilcoxon p = 0.011).
MRI analysis
The radiological analysis was based on images from seven out of the nine patients since only seven patients had a high enough picture quality to allow for adequate evaluation. All spinal cords presented high-intensity signals on the T2-weighted images (T2WI). The changes in the spinal cord signals were distributed as follows: one level of highintensity signal in T2WI in two cases; two levels in three cases; three levels in one case; and four levels in one case. There was no correlation between the number of spinal cord high-intensity signal levels and clinical improvement since a patient with two levels of high-intensity signal in T2WI showed no improvement, while another patient with four levels of spinal cord signal changes had postoperative clinical improvement (Fig. 2) .
Three out of the seven patients had evident spinal cord atrophy, and two of them did not improve clinically. Four patients showed no atrophy and improved clinically (Fisher, p = 0.42).
Comparative analysis between data from patients who improved and those who did not improve
The demographics and clinical characteristics of the patients who returned to walking (postoperative Nurick score B 4) were compared with those of patients who retained a Nurick score of 5 (Table 4) .
There was no significant difference between the ages of patients in both groups. Six patients improved (three females and three males), and three patients had no improvement (all females) (Fisher p = 0.45). The mean length of disease for those who improved was 9.25 ± 7.31 months (95% CI 1.56-16.93), and the mean length of disease for those who did not improve was 38.00 ± 19.28 (95% CI 9.91-85.91) (Mann-Whitney p = 0.02).
Discussion
In 1972, Nurick defined CSM as a generally benign disease with an initial commitment followed by a period of stability, except in elderly patients, in whom the disease tends to have a progressive course [6] . Clarke and Robinson [2] later defined four patterns of the clinical course for CSM in the absence of an operation: slow progression of symptoms with episodes of exacerbation, periods of exacerbation alternating with periods of clinical stabilization, abrupt initial presentation followed by slow progression of symptoms and abrupt initial presentation followed by clinical stabilization. Many authors have described that in the advanced stages of compressive myelopathies, the spinal cord lesion can be irreversible. In these cases, the window for surgery was lost (Fig. 3) [7, 8] .
The clinical status of patients with CSM can be evaluated using scales of neurological and functional assessment; the most cited scales in the literature are the Nurick and JOAm scales. The Nurick scale proposes a score based on symptoms, neurological examination and ability to walk. This score ranges from 0 (less affected) to 5 (most affected) [3] . On the other hand, the JOAm scale evaluates four parameters (motor dysfunction of the upper extremities, motor dysfunction of the lower extremities, sensory dysfunction of the upper extremities and sphincter dysfunction), assigning points for each one separately. The JOAm score ranges from 0 (most affected) to 18 (asymptomatic) [4] .
The JOAm scale was also applied because it allows for the assessment of the four limbs and is more sensitive to clinical changes than the Nurick scale [9] . However, improvement in the JOAm scale does not necessarily represent a functional gain, unlike the Nurick scale, in which the improvement of only one degree means a patient totally dependent (bedridden or in wheelchair) now has partial functional and social independence (able to walk).
Some factors, such as longer time of symptoms, presence of spinal cord signal change and spinal cord atrophy on MRI, advanced disease at the diagnosis and presence of clinical comorbidities are associated with poor prognosis in patients with CSM [10] [11] [12] [13] [14] [15] [16] [17] .
Chiles et al. [18] noted that spinal cord atrophy had a highly significant predictive value in multivariate analyses, but was only weakly predictive when observed in univariate analyses. In the present study, the presence or absence of spinal cord atrophy could be studied in seven patients (Fig. 4) . Among the three patients who had spinal cord atrophy, two did not improve. Four patients had no atrophy, and all of them improved. Although the correlation between atrophy and neurological prognosis is suggestive, the number is too small to reveal significant differences.
Mastronardi et al. [19] found a significant correlation between the surgical results and the length of the patient's clinical history. They also observed a correlation between spinal cord signal presence and the surgical results. Alafifi et al. [20] stated that spinal cord T2WI hyperintense signal was not so absolutely related to the final prognosis but patients who do not have clonus or spasticity may experience a good surgical outcome and may have a reversal of the MRI abnormality. They reported a less favorable surgical outcome in the presence of spinal cord low signal on T1-weighted images (T1WI), clonus or spasticity. Chiles et al. [18] studied the changes of spinal cord signal as a prognostic factor, and they noted that the presence of preoperative signal changes was predictive of a poor surgical outcome, although it was not statistically significant. They attributed this lack of statistical significance to the small number of patients in their study group who presented with this finding. All of the patients in the present study showed highintensity signal on T2WI. This factor could not be correlated with the final neurological outcome. The small number of patients with a Nurick score 5 present in most studies on CSM does not allow a higher correlation between the prognosis and the radiological changes. The strongest data associated with the prognosis in our patients was the length of disease, which is in agreement with the data shown by Mastronardi et al. [19] .
Few studies have presented separate results for each grade in the Nurick scale and the number of seriously ill patients operated on is low, limiting the conclusions of the papers published until now (Table 5 ).
In 1997, Macdonald et al. [21] studied eight cases of CSM with Nurick scores of 5 undergoing surgery and found 50% clinical improvement (improvement of at least one degree in the Nurick scale), in a mean follow-up of 31 months. Alternatively, in 2004, Matsunaga et al. [22] considered 31 patients with Nurick scores of 5 and reported improvement in only 16.2% at a mean follow-up of 211.2 months. Rajshekhar and Kumar [23] , in 2005, evaluated 17 patients and found clinical improvement in 100% of patients with Nurick scores of 5 after 36.3 months of mean follow-up. In the present nine cases of patients with Nurick scores of 5, we found 66.6% clinical improvement in a mean follow-up of 53.4 months. Considering these four papers, a total of 65 patients were studied with a mean follow-up of 82.9 months; an improvement was demonstrated in 51.12 ± 58.16% of the cases (95% CI 41.42-143.68).
Although there is no consensus regarding the natural history of CSM, it is unlikely that patients who are seriously ill, with advanced neurological deficits and radiological findings, can improve without surgical treatment. In contrast, the surgery was able to improve the functional status of most of these patients.
Conclusion
Two-thirds of patients with CSM with a Nurick score of 5, who were either bedridden or in wheelchairs at the diagnosis, improved at least one degree on Nurick scale after surgical treatment, thus regaining the ability to walk. The JOAm scale was more sensitive in detecting clinical changes than the Nurick scale. Patients with longer lengths of disease had poorer outcomes. Year year of publication, n number of Nurick 5 patients studied Improvement rates are expressed in percentage of cases
